BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28405842)

  • 1. EGFR-targeting peptide-coupled platinum(IV) complexes.
    Mayr J; Hager S; Koblmüller B; Klose MHM; Holste K; Fischer B; Pelivan K; Berger W; Heffeter P; Kowol CR; Keppler BK
    J Biol Inorg Chem; 2017 Jun; 22(4):591-603. PubMed ID: 28405842
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the stability and biological behavior of cyclometallated Pt(IV) complexes with halido and aryl ligands in the axial positions.
    Escolà A; Crespo M; López C; Quirante J; Jayaraman A; Polat IH; Badía J; Baldomà L; Cascante M
    Bioorg Med Chem; 2016 Nov; 24(22):5804-5815. PubMed ID: 27670096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide-Coated Platinum Nanoparticles with Selective Toxicity against Liver Cancer Cells.
    Shoshan MS; Vonderach T; Hattendorf B; Wennemers H
    Angew Chem Int Ed Engl; 2019 Apr; 58(15):4901-4905. PubMed ID: 30561882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
    Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of equatorial and axial carboxylato ligands on the kinetic inertness of platinum(IV) complexes in the presence of ascorbate and cysteine and within DLD-1 cancer cells.
    Chen CK; Zhang JZ; Aitken JB; Hambley TW
    J Med Chem; 2013 Nov; 56(21):8757-64. PubMed ID: 24107138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward overcoming cisplatin resistance via sterically hindered platinum(II) complexes.
    Yu H; Gou S; Wang Z; Chen F; Fang L
    Eur J Med Chem; 2016 May; 114():141-52. PubMed ID: 26974381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation.
    Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Yang B; Koppireddi S; Lin Y; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2018 Jan; 143():1039-1052. PubMed ID: 29232581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, characterization and biological investigation of platinum(ii) complexes with asparagusic acid derivatives as ligands.
    Hildebrandt J; Trautwein R; Kritsch D; Häfner N; Görls H; Dürst M; Runnebaum IB; Weigand W
    Dalton Trans; 2019 Jan; 48(3):936-944. PubMed ID: 30565617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vitro Anticancer Evaluation of Platinum(II/IV) Complexes with Diisoamyl Ester of (S,S)-ethylenediamine-N,N'-di-2-propanoic Acid.
    Zmejkovski BB; Pantelić N; Filipović L; Aranđelović S; Radulović S; Sabo TJ; Kaluđerović GN
    Anticancer Agents Med Chem; 2017; 17(8):1136-1143. PubMed ID: 27928952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, biological evaluation and SAR studies of novel bicyclic antitumor platinum(IV) complexes.
    Lorenzo J; Delgado A; Montaña ÁM; Mesas JM; Alegre MT; Rodríguez Mdel C; Avilés FX
    Eur J Med Chem; 2014 Aug; 83():374-88. PubMed ID: 24980119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A dual-targeting hybrid platinum(IV) prodrug for enhancing efficacy.
    Xiao H; Yan L; Zhang Y; Qi R; Li W; Wang R; Liu S; Huang Y; Li Y; Jing X
    Chem Commun (Camb); 2012 Nov; 48(87):10730-2. PubMed ID: 23012698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. trans-Dichloridopalladium(II) and platinum(II) complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine: synthesis, structural characterization, DNA binding and in vitro cytotoxicity studies.
    Icsel C; Yilmaz VT; Ari F; Ulukaya E; Harrison WT
    Eur J Med Chem; 2013 Feb; 60():386-94. PubMed ID: 23314052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Second-generation testosterone-platinum(II) hybrids for site-specific treatment of androgen receptor positive prostate cancer: Design, synthesis and antiproliferative activity.
    Ouellette V; Côté MF; Gaudreault RC; Tajmir-Riahi HA; Bérubé G
    Eur J Med Chem; 2019 Oct; 179():660-666. PubMed ID: 31279298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2-Deoxyglucose conjugated platinum (II) complexes for targeted therapy: design, synthesis, and antitumor activity.
    Mi Q; Ma Y; Gao X; Liu R; Liu P; Mi Y; Fu X; Gao Q
    J Biomol Struct Dyn; 2016 Nov; 34(11):2339-50. PubMed ID: 26524393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of SREBP-mediated lipid biosynthesis and activation of multiple anticancer mechanisms by platinum complexes: Ascribe possibilities of new antitumor strategies.
    Bai X; Ali A; Wang N; Liu Z; Lv Z; Zhang Z; Zhao X; Hao H; Zhang Y; Rahman FU
    Eur J Med Chem; 2022 Jan; 227():113920. PubMed ID: 34742012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced Cytotoxicity and Reactivity of a Novel Platinum(IV) Family with DNA-Targeting Naphthalimide Ligands.
    Navas F; Mendes F; Santos I; Navarro-Ranninger C; Cabrera S; Quiroga AG
    Inorg Chem; 2017 Jun; 56(11):6175-6183. PubMed ID: 28488859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological evaluation of a Platinum(II)-c(RGDyK) conjugate for integrin-targeted photodynamic therapy.
    Chatzisideri T; Thysiadis S; Katsamakas S; Dalezis P; Sigala I; Lazarides T; Nikolakaki E; Trafalis D; Gederaas OA; Lindgren M; Sarli V
    Eur J Med Chem; 2017 Dec; 141():221-231. PubMed ID: 29031069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel clioquinol and its analogous platinum complexes: importance, role of the halogen substitution and the hydroxyl group of the ligand.
    Martín Santos C; Cabrera S; Ríos-Luci C; Padrón JM; López Solera I; Quiroga AG; Medrano MA; Navarro-Ranninger C; Alemán J
    Dalton Trans; 2013 Oct; 42(37):13343-8. PubMed ID: 23945635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxicity profile of novel sterically hindered platinum(II) complexes with (1R,2R)-N(1),N(2)-dibutyl-1,2-diaminocyclohexane.
    Zhang H; Gou S; Zhao J; Chen F; Xu G; Liu X
    Eur J Med Chem; 2015; 96():187-95. PubMed ID: 25874342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.